Google AdsNutraceuticals / Weight LossAd Rejections

GLP-1 Ads Rejected by Google

Your GLP-1 ads rejected by Google. Why semaglutide and tirzepatide campaigns get flagged and how to resubmit for approval.

April 26, 2026


Your GLP-1 ads rejected by Google. If you're advertising semaglutide, tirzepatide, or any GLP-1 weight loss product, Google's health policies will catch your campaigns.

Why GLP-1 Ads Get Rejected on Google

GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are prescription-only drugs in most markets. Advertising prescription drugs is restricted or prohibited on Google.

What's Required to Advertise GLP-1 Products on Google

In most cases, GLP-1 advertising requires: verification that ads target only regions where the product is legally marketed, a landing page that doesn't facilitate prescription fulfillment online, and compliance with all medical advertising regulations.

Ready to Run Compliant Weight Loss Ads on Google?

Auxon Growth manages health and weight loss advertising across Google and other platforms. Book a free strategy call.

Related Resources